Interpace Biosciences, Inc. (IDXG)
USD 2.41
(-9.06%)
USD 2.41
(-9.06%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.19 Million USD | -30.45% |
| 2022 | 16.09 Million USD | 17.32% |
| 2021 | 13.71 Million USD | 189.12% |
| 2020 | 4.74 Million USD | -33.15% |
| 2019 | 7.09 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 7.9 Million USD | -5.82% |
| 2015 | 8.39 Million USD | -69.08% |
| 2014 | 27.15 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 100 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 10.57 Million USD | -5.51% |
| 2024 Q2 | 8.38 Million USD | -20.67% |
| 2023 FY | 11.19 Million USD | -30.45% |
| 2023 Q1 | 15.62 Million USD | -2.91% |
| 2023 Q3 | 13.53 Million USD | -9.14% |
| 2023 Q2 | 14.89 Million USD | -4.65% |
| 2023 Q4 | 11.19 Million USD | -17.31% |
| 2022 FY | 16.09 Million USD | 17.32% |
| 2022 Q2 | 16 Million USD | 11.67% |
| 2022 Q1 | 14.33 Million USD | 4.49% |
| 2022 Q3 | 13.34 Million USD | -16.65% |
| 2022 Q4 | 16.09 Million USD | 20.62% |
| 2021 Q4 | 13.71 Million USD | 12.18% |
| 2021 Q2 | 11.84 Million USD | 25.17% |
| 2021 Q3 | 12.22 Million USD | 3.23% |
| 2021 FY | 13.71 Million USD | 189.12% |
| 2021 Q1 | 9.46 Million USD | 99.45% |
| 2020 Q4 | 4.74 Million USD | -4.93% |
| 2020 Q3 | 4.99 Million USD | -42.39% |
| 2020 FY | 4.74 Million USD | -33.15% |
| 2020 Q1 | 3.99 Million USD | -43.7% |
| 2020 Q2 | 8.66 Million USD | 116.8% |
| 2019 Q2 | 2.31 Million USD | -4.66% |
| 2019 Q4 | 7.09 Million USD | -10.27% |
| 2019 Q1 | 2.42 Million USD | 0.0% |
| 2019 Q3 | 7.9 Million USD | 242.04% |
| 2019 FY | 7.09 Million USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q1 | 4.36 Million USD | -44.82% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q4 | 7.9 Million USD | -12.36% |
| 2016 FY | 7.9 Million USD | -5.82% |
| 2016 Q3 | 9.02 Million USD | 2.42% |
| 2016 Q2 | 8.81 Million USD | 2.44% |
| 2016 Q1 | 8.6 Million USD | 2.42% |
| 2015 Q2 | 27.69 Million USD | 1.26% |
| 2015 Q3 | 27.91 Million USD | 0.78% |
| 2015 Q4 | 8.39 Million USD | -69.92% |
| 2015 FY | 8.39 Million USD | -69.08% |
| 2015 Q1 | 27.34 Million USD | 0.72% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 27.15 Million USD | 0.0% |
| 2014 FY | 27.15 Million USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | 0.0% |
| 1998 Q4 | - USD | -100.0% |
| 1998 Q2 | - USD | -100.0% |
| 1998 FY | - USD | -100.0% |
| 1997 FY | 100 Thousand USD | 0.0% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -399.643% |
| Arrayit Corporation | 1.07 Million USD | -938.058% |
| Atlantic International Corp. | 2.93 Million USD | -281.916% |
| Biocept, Inc. | 12.1 Million USD | 7.573% |
| Bioqual, Inc. | 3.58 Million USD | -212.017% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -15313.006% |
| DermTech, Inc. | 54.39 Million USD | 79.424% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 97.628% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -131.529% |
| iMD Companies, Inc. | 1.12 Million USD | -899.153% |
| IDenta Corp. | 789.14 Thousand USD | -1318.242% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -25426.286% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | -39.119% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -192.533% |
| NovelStem International Corp. | 3.57 Million USD | -213.098% |
| Optigenex Inc. | 8.94 Million USD | -25.18% |
| PharmChem, Inc. | 77.35 Thousand USD | -14368.734% |
| Proteome Sciences plc | 17.15 Million USD | 34.755% |
| Response Genetics, Inc | 6.37 Million USD | -75.616% |
| Rennova Health, Inc. | 15.32 Million USD | 26.99% |
| RushNet, Inc. | 4.82 Million USD | -132.05% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -5305.875% |
| Stella Diagnostics Inc. | 6.2 Million USD | -80.496% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -521.749% |
| Todos Medical Ltd. | 38.34 Million USD | 70.815% |